TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

TELA TELA Bio, Inc.

Market Closed 11-13 16:00:00 EST

0.8201

-0.0399

-4.64%

盘后0.8201

+0.00000.00%

16:10 EST

High0.8356	Low0.7600	Vol129.18K
Open0.8200	D1 Closing0.8600	Amplitude8.79%
Mkt Cap37.02M	Tradable Cap17.50M	Total Shares45.14M
T/O104.21K	T/O Rate0.61%	Tradable Shares21.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"TELA","market":"US","secType":"STK","nameCN":"TELA Bio, Inc.","latestPrice":0.8201,"timestamp":1794603600000,"preClose":0.86,"halted":0,"volume":129176,"hourTrading":{"tag":"盘后","latestPrice":0.8201,"preClose":0.8201,"latestTime":"16:10 EST","volume":6,"amount":4.9206,"timestamp":1794604204409,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.04639534883720923,"floatShares":21344699,"shares":45143410,"eps":-0.777583,"marketStatus":"Market Closed","change":-0.0399,"latestTime":"11-13 16:00:00 EST","open":0.82,"high":0.8356,"low":0.76,"amount":104210,"amplitude":0.087907,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-0.777583,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794819600000},"marketStatusCode":7,"adr":0,"listingDate":1573189200000,"exchange":"NASDAQ","adjPreClose":0.86,"postHourTrading":{"tag":"盘后","latestPrice":0.8201,"preClose":0.8201,"latestTime":"16:10 EST","volume":6,"amount":4.9206,"timestamp":1794604204409,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.5165345770099842,"impliedVol":1.6637,"impliedVolPercentile":0.8088},"requestUrl":"/m/hq/s/TELA/wiki","defaultTab":"wiki","newsList":[{"id":"2683630456","title":"TELA Bio Earnings Call Signals Gradual Growth Recovery","url":"https://stock-news.laohu8.com/highlight/detail?id=2683630456","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683630456?lang=en_us&edition=fundamental","pubTime":"2026-11-15 11:16","pubTimestamp":1794712607,"startTime":"0","endTime":"0","summary":"Tela Bio, Inc. (($TELA)) has held its Q3 earnings call. Read on for the main highlights of the call. TELA Bio’s earnings call carried a broadly pos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-earnings-call-signals-gradual-growth-recovery?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-earnings-call-signals-gradual-growth-recovery?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683517003","title":"Tenon Medical Q3 Revenue Rises as Procedure Volume Grows","url":"https://stock-news.laohu8.com/highlight/detail?id=2683517003","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683517003?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:19","pubTimestamp":1794518354,"startTime":"0","endTime":"0","summary":"Tenon Medical Q3 revenue rises as procedure volume growsOverviewUS sacro-pelvic device maker's Q3 revenue rose 22% yr/yr to $1.4 mlnNet loss widened due to non-cash warrant and interest expensesCompan","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1F7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","BK4082","TNON","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2683886510","title":"Sanara MedTech Q3 Revenue Misses Estimates on Soft Tissue Product Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2683886510","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2683886510?lang=en_us&edition=fundamental","pubTime":"2026-11-13 05:19","pubTimestamp":1794518352,"startTime":"0","endTime":"0","summary":"Sanara MedTech Q3 revenue misses estimates on soft tissue product salesOverviewUS surgical products maker's Q3 revenue rose 8% yr/yr but missed analyst expectationsAdjusted EBITDA for Q3 increased to ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261112:nL2N46T1HI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBIO","BK4198","SMTI","BK4121","TELA","BK4082","ICU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682307316","title":"Analysts Offer Insights on Healthcare Companies: REPRO-MED Systems (KRMD), Legend Biotech (LEGN) and TELA Bio (TELA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2682307316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682307316?lang=en_us&edition=fundamental","pubTime":"2026-11-11 21:40","pubTimestamp":1794404436,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on REPRO-MED Systems (KRMD), Legend Biotech (LEGN) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-repro-med-systems-krmd-legend-biotech-legn-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-repro-med-systems-krmd-legend-biotech-legn-and-tela-bio-tela-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KRMD","XLV","HCSG","MEDI","BK4585","XBI","BK4198","TELA","LEGN","LU0029874061.USD","CANC","MEMS","BK4082","BK4588","BK4505","LABU","BK4139","LU0128526141.USD","BK4137","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682344378","title":"Sanuwave Health Q3 Revenue Falls on Regulatory Uncertainity, Lower Ultramist System Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2682344378","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682344378?lang=en_us&edition=fundamental","pubTime":"2026-11-11 06:12","pubTimestamp":1794348747,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Q3 revenue falls on regulatory uncertainity, lower Ultramist system salesOverviewWound care products provider's Q3 revenue fell 24% yr/yrCompany posted Q3 operating loss, compared to o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nL2N46R1AI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","BK4198","SGRY","TELA","BK4082","SNWV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682412983","title":"TELA Bio Inc Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2682412983","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682412983?lang=en_us&edition=fundamental","pubTime":"2026-11-11 06:01","pubTimestamp":1794348080,"startTime":"0","endTime":"0","summary":"TELA Bio Inc reports results for the quarter ended September 30 - Earnings SummaryTELA Bio IncTELA.OQreported a quarterly adjusted loss of 16 cents per share for the quarter ended September 30, higher","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nL5N46R2N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682344341","title":"TELA Bio - May Offer up to $150 Mln in Securities - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2682344341","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682344341?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:48","pubTimestamp":1794347291,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nFWN46R2C5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682346955","title":"TELA Bio Q3 Revenue Misses Analyst Estimates on Lower OviTex PRS Volumes","url":"https://stock-news.laohu8.com/highlight/detail?id=2682346955","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682346955?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:10","pubTimestamp":1794345001,"startTime":"0","endTime":"0","summary":"TELA Bio Q3 revenue misses analyst estimates on lower OviTex PRS volumesOverviewUS soft-tissue reconstruction firm's Q3 revenue fell 8% yr/yr, missing analyst expectationsAdjusted loss per share for Q","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nL2N46R14Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4185","SGRY","BK4198","OFIX","TELA","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682578345","title":"TELA Bio Q3 Revenue USD 18.959 Million Vs. IBES Estimate USD 20 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682578345","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682578345?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:01","pubTimestamp":1794344461,"startTime":"0","endTime":"0","summary":"BRIEF-TELA Bio Q3 Revenue USD 18.959 Million Vs. IBES Estimate USD 20 MillionNov 10  - TELA Bio Q3 net income USD -9.302 million.Q3 gross profit USD 12.308 millionQ3 income from operations USD -7.29 millionQ3 basic EPS USD -0.16Q3 operating expenses USD 19.598 millionQ3 adjusted EPS USD -0.13 vs. IBES estimate USD -0.16","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nPLXTR85C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682523345","title":"TELA Bio (TELA) Q3: Adj EPS $(0.13) vs $(0.18) Prior; Rev $18.959M vs $20.689M Prior, Down 8% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2682523345","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682523345?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:00","pubTimestamp":1794344428,"startTime":"0","endTime":"0","summary":"TELA Bio (TELA) Q3: Adj EPS $(0.13) vs $(0.18) Prior; Rev $18.959M vs $20.689M Prior, Down 8% Y/Y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/TELA","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"TELA Bio (TELA) Q3: Adj EPS $(0.13) vs $(0.18) Prior; Rev $18.959M vs $20.689M Prior, Down 8% Y/Y","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682345322","title":"TELA Bio Q3 Adjusted EPS USD -0.13 VS. Ibes Estimate USD -0.16","url":"https://stock-news.laohu8.com/highlight/detail?id=2682345322","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682345322?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:00","pubTimestamp":1794344401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nPLXTR85C3:7","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682345310","title":"TELA Bio Q3 Net Income USD -9.302 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2682345310","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2682345310?lang=en_us&edition=fundamental","pubTime":"2026-11-11 05:00","pubTimestamp":1794344401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261110:nPLXTR85C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681890103","title":"TELA Bio Inc Expected to Post a Loss of 16 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2681890103","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681890103?lang=en_us&edition=fundamental","pubTime":"2026-11-07 07:59","pubTimestamp":1794009561,"startTime":"0","endTime":"0","summary":"TELA Bio Inc <TELA.OQ> expected to post a loss of16cents a share - Earnings PreviewTELA Bio IncTELA.OQTELA.Ois expected to  show a fall in quarterly revenue when it reports  results on November 10 for","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nL5N46N2RR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681894672","title":"TELA Bio Grants 108,550 Restricted Stock Units to Four New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2681894672","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681894672?lang=en_us&edition=fundamental","pubTime":"2026-11-07 05:05","pubTimestamp":1793999149,"startTime":"0","endTime":"0","summary":"TELA Bio Grants 108,550 Restricted Stock Units to Four New EmployeesTELA Bio granted restricted stock units covering 108,550 common shares to four newly hired employees, effective November 4, 2026.Awa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nNDL5w6Gjx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BCDF","LU2210149790.SGD","BK4112","SG9999014013.SGD","IE00BQXX3D17.EUR","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BN0W2T93.GBP","SG9999014021.USD","LU2210150020.SGD","BK4588","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","SG9999014039.USD","BK4198","NDAQ","TELA","SG9999014005.SGD","IE00BQXX3C00.GBP","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681920278","title":"TELA Bio Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681920278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681920278?lang=en_us&edition=fundamental","pubTime":"2026-11-07 05:05","pubTimestamp":1793999100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nTUA5VMJR9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681894135","title":"TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681894135","media":"GlobeNewswire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681894135?lang=en_us&edition=fundamental","pubTime":"2026-11-07 05:05","pubTimestamp":1793999100,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Nov.  06, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction so","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/11/06/3397884/0/en/tela-bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LCLG","TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678485337","title":"TELA Bio to Announce Third Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2678485337","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678485337?lang=en_us&edition=fundamental","pubTime":"2026-10-28 04:05","pubTimestamp":1793131500,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., Oct.  27, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (\"TELA Bio\") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction so","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/27/3389595/0/en/tela-bio-to-announce-third-quarter-2026-financial-results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674400076","title":"TELA Bio Shareholders Approve Future Reverse Split Flexibility","url":"https://stock-news.laohu8.com/highlight/detail?id=2674400076","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674400076?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:32","pubTimestamp":1791491542,"startTime":"0","endTime":"0","summary":"The latest announcement is out from TELA Bio ( ($TELA) ). On October 8, 2026, TELA Bio, Inc. held a virtual Special Meeting of Stockholders to cons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-shareholders-approve-future-reverse-split-flexibility?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-shareholders-approve-future-reverse-split-flexibility?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4198","TELA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674045007","title":"TELA Bio Holds Special Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2674045007","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674045007?lang=en_us&edition=fundamental","pubTime":"2026-10-09 04:07","pubTimestamp":1791490042,"startTime":"0","endTime":"0","summary":"TELA Bio holds special stockholder meetingTELA Bio held a special meeting of stockholders on Oct. 8, 2026.Stockholders adopted an amendment to the certificate of incorporation authorizing a potential ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261008:nNDL13vdsh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TELA","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673065518","title":"TELA Bio Regains Nasdaq Compliance, Securing Listing Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2673065518","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673065518?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:37","pubTimestamp":1791319027,"startTime":"0","endTime":"0","summary":"TELA Bio ( ($TELA) ) has shared an update. On October 5, 2026, TELA Bio, Inc. disclosed that it had received notification from The Nasdaq Stock Mar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tela-bio-regains-nasdaq-compliance-securing-listing-status?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tela-bio-regains-nasdaq-compliance-securing-listing-status?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NQmain","BK4198","TELA","LCLG"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.telabio.com","stockEarnings":[{"period":"1week","weight":0.0001},{"period":"1month","weight":-0.2511},{"period":"3month","weight":0.2729},{"period":"6month","weight":-0.0938},{"period":"1year","weight":-0.2612},{"period":"ytd","weight":-0.305}],"compareEarnings":[{"period":"1week","weight":0.0259},{"period":"1month","weight":-0.0198},{"period":"3month","weight":-0.0283},{"period":"6month","weight":0.0206},{"period":"1year","weight":0.1225},{"period":"ytd","weight":0.1062}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.024622},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.021438},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.222765},{"month":4,"riseRate":0.285714,"avgChangeRate":0.009305},{"month":5,"riseRate":0.857143,"avgChangeRate":0.115004},{"month":6,"riseRate":0.428571,"avgChangeRate":0.019526},{"month":7,"riseRate":0.142857,"avgChangeRate":-0.036243},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.02363},{"month":9,"riseRate":0.571429,"avgChangeRate":0.044463},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.103387},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.008465},{"month":12,"riseRate":0.571429,"avgChangeRate":0.074086}],"exchange":"NASDAQ","name":"TELA Bio, Inc.","nameEN":"TELA Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"TELA Bio, Inc.,TELA,TELA Bio, Inc.股票,TELA Bio, Inc.股票老虎,TELA Bio, Inc.股票老虎国际,TELA Bio, Inc.行情,TELA Bio, Inc.股票行情,TELA Bio, Inc.股价,TELA Bio, Inc.股市,TELA Bio, Inc.股票价格,TELA Bio, Inc.股票交易,TELA Bio, Inc.股票购买,TELA Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"TELA Bio, Inc.(TELA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest TELA Bio, Inc.(TELA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction